A study in Japanese and Caucasian subjects with subcutaneous atacicept

  • Research type

    Research Study

  • Full title

    A phase I, double-blind, randomized, placebo-controlled, single-dose, parallel-group trial of subcutaneous atacicept in healthy Japanese and matched Caucasian subjects to assess the safety, tolerability, pharmacokinetics and pharmacodynamics

  • IRAS ID

    137124

  • Contact name

    Arpeat Kaviya

  • Contact email

    arpeat.kaviya@quintiles.com

  • Sponsor organisation

    Merck KGaA

  • Eudract number

    2013-002703-34

  • REC name

    HSC REC B

  • REC reference

    13/NI/0128

  • Date of REC Opinion

    7 Oct 2013

  • REC opinion

    Further Information Favourable Opinion